openPR Logo

Press Releases from DelveInsight Business Research (591 total)

Maple Syrup Urine Disease Therapeutic Pipeline Analysis | Insights into the Late …

"Maple Syrup Urine Disease Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Maple Syrup Urine Disease Therapeutics Market. The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities

Malignant Melanoma Pipeline Assessment | Insights into the Current Therapies, Em …

"Malignant Melanoma Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Malignant Melanoma Therapeutics Market. The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products

HER2 negative Breast Cancer Pipeline involves 85+ key companies continuously wor …

DelveInsight's HER2 negative Breast Cancer Pipeline Insight 2022 report offers exhaustive global coverage of available, marketed, and pipeline therapies in different phases of clinical development, major pharmaceutical companies working to advance the pipeline space, and future growth potential of the HER2 negative Breast Cancer pipeline domain. Some of the essential takeaways from the HER2 negative Breast Cancer Pipeline report: • DelveInsight's HER2 negative Breast Cancer Pipeline analysis depicts a robust space with

Allergic Rhinitis Pipeline involves 32+ key companies continuously working towar …

DelveInsight's 'Allergic Rhinitis Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline Allergic Rhinitis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Allergic Rhinitis pipeline domain. Key Takeaways from the Allergic Rhinitis Pipeline Report • DelveInsight's Allergic Rhinitis Pipeline analysis depicts a robust space with 32+ active players working to develop 32+ pipeline therapies

Pompe Disease Pipeline Assessment (2022): In-depth Analysis of Clinical Trials, …

Pompe Disease pipeline constitutes 15+ key companies continuously working towards developing 20+ Pompe Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Pompe Disease Overview Pompe disease belongs to the 'lysosomal storage disorders' (LSDs) group of diseases. Within the cells, lysosomes are tiny compartments where all sorts of substances are recycled. By the action of digestive enzymes, the compounds are degraded.

Atrial Fibrillation Pipeline Assessment (2022): In-depth Analysis of Clinical Tr …

Atrial Fibrillation pipeline constitutes 5+ key companies continuously working towards developing 5+ Atrial Fibrillation treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Atrial Fibrillation Overview Atrial Fibrillation is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. During atrial fibrillation, the heart's two upper chambers (the atria) beat chaotically and irregular

Hereditary Hemochromatosis (HH) Market to Witness Growth by 2032, Estimates Delv …

DelveInsight's "Hereditary Hemochromatosis (HH) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hereditary Hemochromatosis (HH), historical and forecasted epidemiology as well as the Hereditary Hemochromatosis (HH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Hereditary Hemochromatosis (HH) market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and

H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …

DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,

IgA Nephropathy Pipeline Assessment | Insights into the Current Therapies, Emerg …

As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the IgA Nephropathy therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "IgA Nephropathy Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis

Diamond-Blackfan anemia (DBA) / Aase Syndrome Market to Witness Growth by 2032, …

DelveInsight's "Diamond-Blackfan anemia (DBA) / Aase Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Diamond-Blackfan anemia (DBA) / Aase Syndrome, historical and forecasted epidemiology as well as the Diamond-Blackfan anemia (DBA) / Aase Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Diamond-Blackfan anemia (DBA) / Aase Syndrome market report provides current treatment practices, emerging

Dengue Fever Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Dengue Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Dengue Fever, historical and forecasted epidemiology, as well as the Dengue Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Dengue Fever market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Dengue Fever market

Congenital Hyperinsulinism Market to Exhibit Moderate Growth Rate till 2032, Inv …

DelveInsight's "Congenital Hyperinsulinism Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Congenital Hyperinsulinism Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). The Congenital Hyperinsulinism market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size

Peanut Allergy Pipeline Landscape Analysis of 15+ Companies by DelveInsight

Peanut Allergy Pipeline constitutes 15+ key companies continuously working towards developing 15+ Peanut Allergy Treatment therapies, analyzed DelveInsight Peanut Allergy Pipeline Report provides comprehensive global coverage of available, marketed, and pipeline Peanut Allergy therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Peanut Allergy Pipeline Domain. Key takeaways from the Peanut Allergy Pipeline Report • DelveInsight's Peanut Allergy Pipeline analysis

Prostate Cancer Pipeline Landscape Analysis of 200+ Companies by DelveInsight

Prostate Cancer Pipeline constitutes 200+ key companies continuously working towards developing 45+ Prostate Cancer Treatment therapies, analyzed DelveInsight Prostate Cancer Pipeline Report provides comprehensive global coverage of available, marketed, and pipeline Prostate Cancer therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Prostate Cancer Pipeline Domain. Key takeaways from the Prostate Cancer Pipeline Report • DelveInsight's Prostate Cancer Pipeline Report

Hepatitis D Virus Pipeline Assessment | Insights into the Current Therapies, Eme …

As per DelveInsight's assessment, globally, about 6+ key pharma and biotech companies are working on 6+ pipeline drugs in the Hepatitis D Virus therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Hepatitis D Virus Pipeline Insight, 2022" report by DelveInsight provides a

Human Immunodeficiency Virus Type-1 (HIV-1) Therapeutic Pipeline Analysis | Insi …

As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Human Immunodeficiency Virus Type-1 (HIV-1) therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Human Immunodeficiency Virus Type-1 (HIV-1) Pipeline Insight, 2022" report

Angelman Syndrome Pipeline Assessment (2022): In-depth Analysis of Clinical Tria …

Angelman Syndrome pipeline constitutes 5+ key companies continuously working towards developing 5+ Angelman Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Angelman Syndrome Overview Angelman syndrome (AS) is a rare neuro-genetic disorder that occurs in one in 15,000 live births or 500,000 people worldwide. It is caused by a loss of function of the UBE3A gene in the 15th chromosome

Chronic Hepatitis B Virus Pipeline Assessment (2022): In-depth Analysis of Clini …

Chronic Hepatitis B Virus pipeline constitutes 40+ key companies continuously working towards developing 40+ Chronic Hepatitis B Virus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Chronic Hepatitis B Virus Overview Hepatitis B virus is a small DNA virus that belongs to the "Hepadnaviridae" family. It is a vaccine-preventable liver infection caused by the HBV. A hepatitis B infection can result

Chronic Granulomatous Disease (CGD) Market to Witness Growth by 2032, Estimates …

DelveInsight's "Chronic Granulomatous Disease (CGD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Granulomatous Disease (CGD), historical and forecasted epidemiology as well as the Chronic Granulomatous Disease (CGD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Granulomatous Disease (CGD) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,

Coxsackievirus Infections Market to Witness Growth by 2032, Estimates DelveInsig …

DelveInsight's "Coxsackievirus Infections Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Coxsackievirus Infections, historical and forecasted epidemiology as well as the Coxsackievirus Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Coxsackievirus Infections market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Coxsackievirus Infections market

Clostridium Difficile Infections Market Drugs are expected to get launched durin …

"Growth of the Clostridium Difficile Infections market is expected to be mainly driven by rise in number of prevalent cases, and rise in the usage of current treatment options" The potential drugs recently launched in the Clostridium Difficile Infections Market or expected to get launched in the market during the study period 2019-2032 The Clostridium Difficile Infections market size is anticipated to increase during the study period, 2019-2032, fuelled with increase in

Hallux Valgus Market Research, Size, and Growth Report | DelveInsight

"Growth of the Hallux Valgus market is expected to be mainly driven by rise in number of prevalent cases, and rise in the usage of current treatment options" The potential drugs recently launched in the Hallux Valgus Market or expected to get launched in the market during the study period 2019-2032 Hallux Valgus Market Research Report is a comprehensive analysis of the study of the Healthcare industry. DelveInsight included in this report

Neutropenia Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Drugs, …

Neutropenia pipeline constitutes 30+ key companies continuously working towards developing 30+ Neutropenia treatment therapies, analyzes DelveInsight Neutropenia refers to lower-than-normal levels of neutrophils in your blood. A neutrophil is a type of white blood cell that your bone marrow primarily makes. White blood cells in general, and neutrophils in particular, fight infections in your body. Neutrophils destroy germs that cause infections, like viruses and bacteria. "Neutropenia Pipeline Insight, 2022" report by DelveInsight

Gastrointestinal Stromal Tumors Pipeline Assessment - FDA, EMA, and PMDA Approva …

Gastrointestinal Stromal Tumors pipeline constitutes 25+ key companies continuously working towards developing 28+ Gastrointestinal Stromal Tumors treatment therapies, analyzes DelveInsight Gastrointestinal stromal tumors (GISTs) are rare neoplasms of the gastrointestinal tract associated with high rates of malignant transformation. Most GISTs present asymptomatically. They are best identified by computed tomography (CT) scan and most stain positive for CD117 (C-Kit), CD34, and/or DOG-1. There have been many risk stratification classifications systems which are

Bipolar Depression Pipeline Drugs and Companies Insight Report: Analysis of Clin …

Bipolar Depression pipeline constitutes 6+ key companies continuously working towards developing 6+ Bipolar Depression treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Bipolar Depression Overview Bipolar disorder is a disabling chronic disease in which depression usually presents a higher risk of long-term functional impairment than mania. Persistent depression does not have a known cause. As with bipolar disorder, depression has hereditary

Neuromyelitis Optica Spectrum Disorder Pipeline Drugs and Companies Insight Repo …

Neuromyelitis Optica Spectrum Disorder pipeline constitutes 15+ key companies continuously working towards developing 15+ Neuromyelitis Optica Spectrum Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Neuromyelitis Optica Spectrum Disorder Overview Neuromyelitis Optica Spectrum Disorder (NMOSD), also known as Devic disease, is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve (optic neuritis) and

Hemorrhoids Pipeline Assessment (2022): In-depth Analysis of Clinical Trials, La …

Hemorrhoids pipeline constitutes 10+ key companies continuously working towards developing 10+ Hemorrhoids treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Hemorrhoids Overview Hemorrhoids, also called piles, are swollen and inflamed veins around the anus or in lower rect#m. The two types of hemorrhoids are external hemorrhoids, which form under the skin around the anus, and internal hemorrhoids, which form in the

Cystic Fibrosis Pipeline Assessment (2022): In-depth Analysis of Clinical Trials …

Cystic Fibrosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Cystic Fibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Cystic Fibrosis Overview Cystic fibrosis (CF) is a recessive genetic disease caused by a mutation in the epithelial chloride channel-cystic fibrosis transmembrane conductance regulator (CFTR). CF is a predominant genetic disorder with a disease severity ranging from mild to

Choroidal Neovascularization Market Is Expected To Grow During The Study Period …

"The increase in Choroidal Neovascularization Market size is a direct consequence of an increase in R& D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM" The potential drugs recently launched in the Choroidal Neovascularization Market or expected to get launched in the market during the study period 2019-2032 The Choroidal Neovascularization market report provides current treatment practices, emerging drugs, Choroidal Neovascularization market share of the individual therapies,

According to DelveInsight's' estimates, Gout Market in 7MM is expected to show p …

"The increase in Gout Market size is a direct consequence of an increase in R& D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM" The potential drugs recently launched in the Gout Market or expected to get launched in the market during the study period 2019-2032 The Gout Market Insights report from DelveInsight provides a thorough understanding of the Gout Market size by treatment, epidemiology, emerging therapies,

Alpha-Mannosidosis Market Is Expected To Grow During the Study Period (2019-2032 …

"The increase in Alpha Mannosidosis Market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM" The potential drugs recently launched in Alpha Mannosidosis Market or expected to get launched in the market during the study period 2019-2032. The Alpha Mannosidosis market report provides current treatment practices, emerging drugs, Alpha Mannosidosis market share of the individual therapies, current and

Alport Syndrome Market Is Expected To Grow During the Study Period (2019-2032), …

"The increase in Alport Syndrome Market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM" The potential drugs recently launched in Alport Syndrome Market or expected to get launched in the market during the study period 2019-2032. The Alport Syndrome market report provides current treatment practices, emerging drugs, Alport Syndrome market share of the individual therapies, current and

Hereditary Transthyretin Amyloidosis (hATTR) Therapeutic Pipeline Analysis | Ins …

As per DelveInsight's assessment, globally, nearly 8+ key pharma and biotech companies are working on 8+ pipeline drugs in the Hereditary Transthyretin Amyloidosis (hATTR) therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Hereditary Transthyretin Amyloidosis Pipeline Insight, 2022" report by DelveInsight provides

Epidermolysis Bullosa Therapeutic Pipeline Assessment | Insights into the Latest …

As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 25+ pipeline drugs in the Epidermolysis Bullosa therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Epidermolysis Bullosa Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis

Larynx Cancer Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Larynx Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Larynx Cancer, historical and forecasted epidemiology as well as the Larynx Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Larynx Cancer market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Larynx Cancer market

Chronic Non-healing Wounds Market to Witness Growth by 2032, Estimates DelveInsi …

DelveInsight's "Chronic Non-healing Wounds Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Non-healing Wounds, historical and forecasted epidemiology as well as the Chronic Non-healing Wounds market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Non-healing Wounds market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and

Fanconi Anemia Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Fanconi Anemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Fanconi Anemia, historical and forecasted epidemiology as well as the Fanconi Anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Fanconi Anemia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Fanconi Anemia market

Aspergillosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Comp …

The Aspergillosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Aspergillosis pipeline products will significantly revolutionize the Aspergillosis market dynamics. DelveInsight's "Aspergillosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Aspergillosis, historical and forecasted epidemiology as well as the Aspergillosis market trends in the United States, EU5 (Germany, Spain, Italy, France,

Tinnitus Pipeline Assessment (2022): In-depth Analysis of Clinical Trials, Lates …

Tinnitus pipeline constitutes 8+ key companies continuously working towards developing 8+ Tinnitus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Tinnitus Overview "Tinnitus Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Tinnitus Market. The Tinnitus Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the

The WHIM Syndrome Market Size was estimated at USD 8 million in 2021

"It is estimated that WHIM Syndrome Treatment space will experience significant changes during the forecast period of 2022-2032, owing to the launch of novel therapies that are in clinical development for the management of WHIM Syndrome Market" The WHIM Syndrome Market report provides current treatment practices, emerging drugs, and their market share of the individual therapies, current and forecasted WHIM Syndrome symptoms market size from 2019 to 2032 segmented by seven

According to DelveInsight, the Social Anxiety Disorder Market in 7MM is expected …

"The increase in Social Anxiety Disorder market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM" The Social Anxiety Disorder market report provides current treatment practices, emerging drugs, Social Anxiety Disorder market share of the individual therapies, current and forecasted Social Anxiety Disorder market Size from 2019 to 2032 segmented by seven major markets. The Report

According to DelveInsight, the Psoriasis Market in 7MM is expected to witness a …

"The increase in Psoriasis market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM" DelveInsight's "Psoriasis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Psoriasis, historical and forecasted epidemiology as well as the Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Key highlights of

The PCSK9 Inhibitors Market to Increase Rapidly During the Forecast Period with …

"The increase in PCSK9 Inhibitors market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM" DelveInsight's PCSK9 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, PCSK9 Inhibitors emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM (the United States, the EU5 (the

Postmenopausal osteoporosis Pipeline Assessment - FDA, EMA, and PMDA Approvals, …

Postmenopausal osteoporosis pipeline constitutes 18+ key companies continuously working towards developing 18+ Postmenopausal osteoporosis treatment therapies, analyzes DelveInsight Menopause can increase your risk of developing osteoporosis, a condition in which bones become thin (less dense) and may fracture easily.The drop in oestrogen levels that occurs around the time of menopause results in increased bone loss. It is estimated that, on average, women lose up to 10 per cent of their bone

Von Willebrand's Disease Pipeline Assessment - FDA, EMA, and PMDA Approvals, Eme …

Von Willebrand's Disease pipeline constitutes 4+ key companies continuously working towards developing 4+ Von Willebrand's Disease treatment therapies, analyzes DelveInsight Most commonly inherited bleeding disorder, first described in the Aland Islands by Erik von Willebrand. It occurs as a result of decrease in plasma levels or defect in von Willebrand factor which is a large multimeric glycoprotein. Monomers of this glycoprotein undergo N-glycosylation to form dimers which get arranged to give

Type 1 Diabetes Therapeutic Pipeline Analysis | Insights into the Latest FDA, EM …

As per DelveInsight's assessment, globally, around 80+ key pharma and biotech companies are working on 100+ pipeline drugs in the Type 1 Diabetes therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Type 1 Diabetes Pipeline Insight, 2022" report by DelveInsight provides a

Acute Myeloid Leukemia Therapeutic Pipeline Analysis | Insights into the Latest …

As per DelveInsight's assessment, globally, nearly 260+ key pharma and biotech companies are working on 260+ pipeline drugs in the Acute Myeloid Leukemia therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Acute Myeloid Leukemia Pipeline Insight, 2022" report by DelveInsight provides a

Human Papillomavirus-positive Oropharyngeal Cancer Market to Witness Growth by 2 …

DelveInsight's "Human Papillomavirus-positive Oropharyngeal Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Human Papillomavirus-positive Oropharyngeal Cancer, historical and forecasted epidemiology as well as the Human Papillomavirus-positive Oropharyngeal Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Human Papillomavirus-positive Oropharyngeal Cancer market report provides current treatment practices, emerging drugs, the market share of the individual therapies,

Hormone Receptor (HR) Positive/ Human Epidermal Receptor 2 (HER2) Negative Breas …

DelveInsight's "Hormone Receptor (HR) Positive/ Human Epidermal Receptor 2 (HER2) Negative Breast Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hormone Receptor (HR) Positive/ Human Epidermal Receptor 2 (HER2) Negative Breast Cancer, historical and forecasted epidemiology as well as the Hormone Receptor (HR) Positive/ Human Epidermal Receptor 2 (HER2) Negative Breast Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United

Myocardial Infarction Pipeline Assessment (2022): In-depth Analysis of Clinical …

Myocardial Infarction pipeline constitutes 50+ key companies continuously working towards developing 50+ Myocardial Infarction treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Myocardial Infarction Overview Myocardial Infarction (MI), colloquially known as "heart attack," is caused by decreased or complete cessation of blood flow to a portion of the myocardium. Myocardial infarction may be "silent" and go undetected, or it could be

Go To Page:   1 2 3 4 5 6 7 8 9 10 11 12